Concepts (102)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intensive Care Units | 5 | 2021 | 328 | 1.050 |
Why?
|
| Positive-Pressure Respiration | 1 | 2021 | 10 | 0.790 |
Why?
|
| Physician-Nurse Relations | 1 | 2015 | 4 | 0.520 |
Why?
|
| Patient Discharge | 3 | 2016 | 164 | 0.510 |
Why?
|
| Acute Lung Injury | 4 | 2016 | 20 | 0.510 |
Why?
|
| Electronic Health Records | 1 | 2015 | 70 | 0.490 |
Why?
|
| Communication | 1 | 2015 | 120 | 0.470 |
Why?
|
| Enteral Nutrition | 4 | 2014 | 56 | 0.400 |
Why?
|
| C-Reactive Protein | 3 | 2016 | 128 | 0.350 |
Why?
|
| Insufflation | 1 | 2007 | 1 | 0.300 |
Why?
|
| Calorimetry | 1 | 2007 | 3 | 0.300 |
Why?
|
| Intubation, Gastrointestinal | 1 | 2007 | 11 | 0.300 |
Why?
|
| Capnography | 1 | 2007 | 10 | 0.300 |
Why?
|
| Carbon Dioxide | 1 | 2007 | 20 | 0.300 |
Why?
|
| Energy Intake | 3 | 2016 | 73 | 0.260 |
Why?
|
| Hospital Mortality | 4 | 2021 | 150 | 0.250 |
Why?
|
| Shock, Septic | 3 | 2012 | 67 | 0.220 |
Why?
|
| Intermittent Positive-Pressure Ventilation | 1 | 2021 | 3 | 0.200 |
Why?
|
| Intubation, Intratracheal | 2 | 2017 | 99 | 0.200 |
Why?
|
| Respiration, Artificial | 3 | 2017 | 117 | 0.190 |
Why?
|
| Dietary Proteins | 3 | 2016 | 25 | 0.170 |
Why?
|
| Anti-Infective Agents | 2 | 2012 | 63 | 0.170 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 820 | 0.160 |
Why?
|
| Humans | 15 | 2021 | 31073 | 0.150 |
Why?
|
| Airway Resistance | 1 | 2017 | 4 | 0.150 |
Why?
|
| Decontamination | 1 | 2017 | 9 | 0.150 |
Why?
|
| Ventilator Weaning | 1 | 2017 | 38 | 0.140 |
Why?
|
| Nutritional Support | 1 | 2016 | 23 | 0.140 |
Why?
|
| Patient Transfer | 1 | 2015 | 21 | 0.120 |
Why?
|
| Protein C | 2 | 2012 | 8 | 0.120 |
Why?
|
| United States | 4 | 2015 | 2376 | 0.120 |
Why?
|
| Leukoencephalitis, Acute Hemorrhagic | 1 | 2013 | 3 | 0.110 |
Why?
|
| Brain Edema | 1 | 2013 | 23 | 0.110 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2013 | 20 | 0.110 |
Why?
|
| Encephalocele | 1 | 2013 | 32 | 0.110 |
Why?
|
| Influenza, Human | 1 | 2013 | 50 | 0.110 |
Why?
|
| Nutrition Therapy | 1 | 2012 | 5 | 0.100 |
Why?
|
| Critical Care | 2 | 2012 | 246 | 0.100 |
Why?
|
| Critical Illness | 1 | 2012 | 141 | 0.090 |
Why?
|
| Proportional Hazards Models | 3 | 2016 | 370 | 0.080 |
Why?
|
| Prospective Studies | 3 | 2014 | 1899 | 0.080 |
Why?
|
| Nursing Audit | 1 | 2007 | 2 | 0.080 |
Why?
|
| Medical Errors | 1 | 2007 | 29 | 0.070 |
Why?
|
| Male | 9 | 2016 | 16499 | 0.070 |
Why?
|
| Point-of-Care Systems | 1 | 2007 | 63 | 0.070 |
Why?
|
| Hypotension | 1 | 2006 | 32 | 0.070 |
Why?
|
| Radiography | 1 | 2007 | 695 | 0.060 |
Why?
|
| Female | 8 | 2016 | 17017 | 0.060 |
Why?
|
| Adult | 6 | 2016 | 8950 | 0.060 |
Why?
|
| Nutritional Status | 2 | 2016 | 46 | 0.060 |
Why?
|
| Middle Aged | 6 | 2016 | 10240 | 0.060 |
Why?
|
| APACHE | 2 | 2014 | 32 | 0.050 |
Why?
|
| Sepsis | 1 | 2003 | 154 | 0.050 |
Why?
|
| Aged | 4 | 2016 | 10082 | 0.040 |
Why?
|
| Recombinant Proteins | 2 | 2012 | 256 | 0.040 |
Why?
|
| Work of Breathing | 1 | 2017 | 4 | 0.040 |
Why?
|
| Mucus | 1 | 2017 | 8 | 0.040 |
Why?
|
| Biofilms | 1 | 2017 | 15 | 0.040 |
Why?
|
| Cross-Over Studies | 1 | 2016 | 73 | 0.030 |
Why?
|
| Cohort Studies | 2 | 2012 | 2046 | 0.030 |
Why?
|
| Hospital Bed Capacity | 1 | 2015 | 6 | 0.030 |
Why?
|
| Blood Cell Count | 1 | 2014 | 17 | 0.030 |
Why?
|
| Parenteral Nutrition | 1 | 2014 | 17 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2014 | 3810 | 0.030 |
Why?
|
| Survival Rate | 2 | 2006 | 407 | 0.030 |
Why?
|
| Autoimmunity | 1 | 2013 | 19 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2013 | 65 | 0.030 |
Why?
|
| Body Weight | 1 | 2014 | 141 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2015 | 428 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2014 | 120 | 0.030 |
Why?
|
| Saudi Arabia | 1 | 2012 | 8 | 0.030 |
Why?
|
| Canada | 1 | 2012 | 54 | 0.030 |
Why?
|
| Propensity Score | 1 | 2012 | 36 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2014 | 453 | 0.020 |
Why?
|
| Length of Stay | 1 | 2012 | 339 | 0.020 |
Why?
|
| Manitoba | 1 | 2006 | 1 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2006 | 293 | 0.020 |
Why?
|
| Prevalence | 1 | 2006 | 499 | 0.010 |
Why?
|
| Gastrointestinal Contents | 1 | 2004 | 2 | 0.010 |
Why?
|
| Gastric Emptying | 1 | 2004 | 13 | 0.010 |
Why?
|
| Sampling Studies | 1 | 2004 | 29 | 0.010 |
Why?
|
| Nutritional Requirements | 1 | 2004 | 12 | 0.010 |
Why?
|
| Vomiting | 1 | 2004 | 18 | 0.010 |
Why?
|
| Nausea | 1 | 2004 | 27 | 0.010 |
Why?
|
| Nutrition Assessment | 1 | 2004 | 34 | 0.010 |
Why?
|
| Diarrhea | 1 | 2004 | 48 | 0.010 |
Why?
|
| Norepinephrine | 1 | 2003 | 21 | 0.010 |
Why?
|
| Ventilators, Mechanical | 1 | 2003 | 23 | 0.010 |
Why?
|
| Vasoconstrictor Agents | 1 | 2003 | 31 | 0.010 |
Why?
|
| Hyperglycemia | 1 | 2003 | 37 | 0.010 |
Why?
|
| Acute Disease | 1 | 2003 | 232 | 0.010 |
Why?
|
| Insulin | 1 | 2003 | 97 | 0.010 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2003 | 105 | 0.010 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2003 | 109 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2003 | 331 | 0.010 |
Why?
|
| Time Factors | 1 | 2006 | 1680 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2006 | 1935 | 0.010 |
Why?
|
| Chicago | 1 | 2004 | 941 | 0.010 |
Why?
|
| Prognosis | 1 | 2003 | 924 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2003 | 420 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2006 | 3665 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2004 | 5197 | 0.010 |
Why?
|